ERBB2 and invasive lobular breast carcinoma: Although the overall response to PST in invasive lobular breast carcinoma is poorer than in invasive ductal tumor type, a better response in TNBC and HER2-positive tumors, and a survival benefit when a pCR is achieved, can also be demonstrated in invasive lobular carcinoma [22].